Protocol for Evidence-based Core Information Guideline for Health Communication of Tobacco Control
1.Evidence-based Communication and Information Management Research Center,College of the Media and Arts,Liaoning Technical University,Fuxin 123000,China
2.School for Policy Studies,University of Bristol,Bristol BS2 8BB,England
3.The Third Clinical Department,China Medical University,Shenyang 110122,China
4.School of Basic Medical Sciences,Shandong University,Jinan 250012,China
5.Health Communication Committee,Chinese Medical Doctor Association,Beijing 100073,China
6.Publicity Department,Party Committee,Affiliated Hospital of Nantong University,Nantong 226019,China
7.Pharmacy Department,Peking University Third Hospital,Beijing 100191,China
8.Key Research Base of Philosophy and Social Sciences in Shaanxi Province,Health Culture Research Center of Shaanxi,Xi'an 712046,China
9.School of Public Health,Peking University,Beijing 100191,China
10.Health Education Department,Qingdao Center for Disease Control and Prevention,Qingdao 266033,China
*Corresponding authors:WU Yibo,Professor;E-mail:bjmuwuyibo@outlook.com
QI Fei,Chief physician;E-mail:Qdqff@163.com
QUAN Chenxi,LIU Jin and WEI Shuting are the first authors
Published:2021-11-05
Online:2021-11-05
控烟健康传播核心信息循证指南制定方案
1.123000辽宁省阜新市,辽宁工程技术大学传媒与艺术学院循证传播与信息管理研究中心 2.BS2 8BB Bristol,School for Policy Studies,University of Bristol,England 3.110122辽宁省沈阳市,中国医科大学临床三系 4.250012山东省济南市,山东大学基础医学院 5.100073北京市,中国医师协会健康传播工作委员会 6.226019江苏省南通市,南通大学附属医院党委宣传部 7.100191北京市,北京大学第三医院药剂科 8.712046陕西省西安市,陕西(高校)哲学社会科学重点研究基地-健康文化研究中心 9.100191北京市,北京大学公共卫生学院 10.266033山东省青岛市疾病预防控制中心健康教育科
*通信作者:吴一波,研究员;E-mail:bjmuwuyibo@outlook.com 綦斐,主任医师;E-mail:Qdqff@163.com
权辰昕、刘今与魏淑婷共同为第一作者
QUAN Chenxi,LIU Jin,WEI Shuting, et al. Protocol for Evidence-based Core Information Guideline for Health Communication of Tobacco Control [J]. Chinese General Practice, 2021, 24(31): 3923-3928. DOI: 10.12114/j.issn.1007-9572.2021.00.245.
权辰昕,刘今,魏淑婷等. 控烟健康传播核心信息循证指南制定方案[J]. 中国全科医学, 2021, 24(31): 3923-3928. DOI: 10.12114/j.issn.1007-9572.2021.00.245.
[1]PARISIS D,BERNIER C,CHASSET F,et al. Impact of tobacco smoking upon disease risk,activity and therapeutic response in systemic lupus erythematosus:a systematic review and meta-analysis[J]. Autoimmun Rev,2019,18(11):102393.
[2]李雯. “控烟”,中国在行动——“中国吸烟危害健康报告,戒烟网站及12320戒烟服务”项目活动侧记[J]. 中国卫生人才,2012,14(9):60-62.
[3]YANG G,WANG Y,WU Y,et al. The road to effective tobacco control in China[J]. The Lancet,2015,385(9972):1019-1028. DOI:10.1016/S0140-6736(15)60174-X.
[4]SI Y,ZHOU Z,SU M,et al. Socio-economic inequalities in tobacco consumption of the older adults in China:a decomposition method[J]. Int J Environ Res Public Health,2018,15(7):1466. DOI:10.3390/ijerph15071466.
[5]MATHERS C D,LONCAR D. Projections of global mortality and burden of disease from 2002 to 2030[J]. PLoS Med,2006,3(11):e442. DOI:10.1371/journal.pmed.0030442.
[6]MOCAN N,ALTINDAG D T. Education,cognition,health knowledge,and health behavior[J]. Eur J Health Econ,2014,15(3):265-279.
[7]GROSSMAN M,HANUSHEK E,WELCH F. Handbook of the Economics of Education[EB/OL]. [2021-03-10]. https://www.sciencedirect.com/handbook/handbook-of-the-economics-of-education.
[8]ROSENZWEIG M R,SCHULTZ T P,FUCHS V. Economic aspects of health[M]. Chicago:University of Chicago Press,1982.
[9]BALA M M,STRZESZYNSKI L,TOPOR-MADRY R. Mass media interventions for smoking cessation in adults[J]. Cochrane DB Syst Rev,2017,11(11):CD004704. DOI:10.1002/14651858.CD004704.pub3.
[10]DAVIS R M. The role of the media in promoting and reducing tobacco use:executive summary[EB/OL]. [2021-03-10]. https://www.docin.com/p-149616721.html.
[11]李莉,田凤华,唐芹,等. 新媒体在健康科普传播中的应用[J]. 中国健康教育,2013,29(2):94-95.
[12]GROL R,ECCLES M,MAISONNEUVE H,et al. Developing clinical practice guidelines[J]. Dis Manag Health Out,1998,4(5):255-266. DOI:10.2165/00115677-199804050-00002.
[13]World Health Organization. WHO handbook for guideline development[EB/OL]. [2021-03-10]. https://www.docin.com/p-339907611.html.
[14]蒋朱明. 制订/修订《临床诊疗指南》的基本方法及程序[J]. 中华医学杂志,2016,96(4):250-253. DOI:10.3760/cma.j.issn.0376-2491.2016.04.004.
[15]GRAHAM R,MANCHER M,WOLMAN D M,et al. Clinical practice guidelines we can trust[EB/OL]. [2021-03-10]. http:www.mendeley.com/catalogue/26c4ca22-41f6-327e-a16b-fa6bf39529c21.
[16]SCHüNEMANN H J,WIERCIOCH W,ETXEANDIA I,et al.
Guidelines 2.0:systematic development of a comprehensive checklist for a successful guideline enterprise[J]. CMAJ,2014,186(3):e123-142. DOI:10.1503/cmaj.131237.
[17]CHEN Y,YANG K,MARU?I? A,et al. A reporting tool for practice guidelines in health care:the RIGHT statement[J]. Ann Int Med,2017,166(2):128-132. DOI:10.1016/j.zefq.2017.10.008.
[18]BROUWERS M C,KHO M E,BROWMAN G P,et al. AGREE Ⅱ:advancing guideline development,reporting and evaluation in health care[J]. CMAJ,2010,182(18):e839-842.
[19]TEEDE H J,MISSO M L,COSTELLO M F,et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome[J]. Hum Reprod,2018,33(9):1602-1618. DOI:10.1016/j.fertnstert.2018.05.004.
[20]SANTOS C M C,PIMENTA C A M,NOBRE M R C. The PICO strategy for the research question construction and evidence search[J]. Rev Lat Am Enfermagem,2007,15(3):508-511. DOI:10.1590/s0104-11692007000300023.
[21]RAYENS M K,HAHN E J. Building consensus using the policy Delphi method[J]. Policy Polit Nurs Pract,2000,1(4):308-315. DOI:10.1136/tc.8.2.137.
[22]SHEA B J,GRIMSHAW J M,WELLS G A,et al. Development of AMSTAR:a measurement tool to assess the methodological quality of systematic reviews[J]. BMC Med Res Methodol,2007,7(1):10. DOI:10.1186/1471-2288-7-10.
[23]GUYATT G,OXMAN A D,AKL E A,et al. GRADE guidelines:1. introduction:GRADE evidence profiles and summary of findings tables[J]. J Clin Epidemiol,2011,64(4):383-394. DOI:10.1016/j.jclinepi.2010.04.026.
[24]STANG A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol,2010,25(9):603-605. DOI:10.1007/s10654-010-9491-z.
[25]VAN WERSCH A,ECCLES M. Involvement of consumers in the development of evidence based clinical guidelines:practical experiences from the North of England evidence based guideline development programme[J]. BMJ Qual Saf,2001,10(1):10-16. DOI:10.1136/qhc.10.1.10.
[26]ECCLES M,MASON J,FREEMANTLE N. Developing valid cost effectiveness guidelines:a methodological report from the North of England evidence based guideline development project[J]. BMJ Qual Saf,2000,9(2):127-132.